Guimaraes, D.A., dos Santos, M.S., Gomes, K.B., van der Bom, J.G., Rios, D.R., Cardoso, J., Franco, R.M., Teixeira, G.S., Dusse, L.M., Carvalho, M. and Fernandes, A.P. (2012) Interaction between Oral Estrogen plus Progestogen Therapy and ABO Blood Groups on Coagulation Activation in Postmenopausal Women. Menopause, 19, 339-345.
https://doi.org/10.1097/gme.0b013e31822b721f

has been cited by the following article:

• TITLE: Contraception and Venous Thromboembolism: Risk Factors and Clinical Considerations

  AUTHORS: Ashley Waddington, Carrie Ferguson, Robert L. Reid

  KEYWORDS: Venous Thromboembolism, Family History, Contraception

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.7 No.1, December 23, 2016

  ABSTRACT: Venous thromboembolism (VTE) is a known risk with some forms of hormonal contraception, and should be considered by health care providers when counselling patients about their contraceptive options. Various other risk factors exist for VTE, including family history of VTE and a personal history of VTE or thrombophilia. This article will summarize various known risk factors for VTE, as well as what is known about the VTE risk imparted by the use of different contraceptives.